Pell Bio-Med Technology Co., Ltd.

NT$37.55As of Sun 8 Nov 2026, 12:00 UTC
TWSE:6949Healthcare
Country Taiwan
PE (Fwd) •••
TSR 3Y CAGR 135.32%
Div yield —
ROE (24.19%)
Biotechnology
Beta (5Y) 1.61
PE TTM —
TSR TTM 106.95%
Mkt cap NT$49.21B
ROIC (13.67%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
NT$39
2.57%
(30.82%)
Hold 11|1|4|11|5
4Q25
1Q26
2Q26
3Q26
Earnings per shareNT$
0.66
0.73
0.75
0.73
25.27%
31.71%
22.97%
17.38%
RevenueNT$B
2.403
2.343
2.456
2.575
2.73%
0.63%
6.43%
12.65%
Peers (US$1.486B)
Cap (US$)
PE
651.0M
354.8x
1.488B
—
Capital
TTM
5Y
10Y
Leveragex
3.055
0.215
0.181
EBIT/Intx
0.493
0.490
0.481
Own earn%
(7.80)
(40.19)
(39.23)
Sh yield%
16.94
64.99
62.96
Owners
Insiders/Inst%
8.71
26.14
Short interest%
1.27
SBC / revenue%
4.41
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
19
Op margin range%
29–34
$1 testx
0.0
Incr. ROIC%
1